DarioHealth agrees to acquire computer vision tech developer Physimax

DarioHealthDarioHealth (NSDQ:DRIO) announced today that it entered into an agreement to acquire Physimax Technologies.

Physimax develops computer vision (CV) technology for musculoskeletal (MSK) functional screening and predictive risk of injury assessment.

The technology is currently used commercially by National Basketball Association and National Football League teams, the U.S. military